Drug Shortage Report for PRALUENT
| Report ID | 209523 |
| Drug Identification Number | 02453819 |
| Brand name | PRALUENT |
| Common or Proper name | PRALUENT |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALIROCUMAB |
| Strength(s) | 75MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 2 |
| ATC code | C10AX |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2023-11-13 |
| Actual start date | |
| Estimated end date | 2023-12-22 |
| Actual end date | 2023-12-22 |
| Shortage status | Resolved |
| Updated date | 2024-01-02 |
| Company comments | SUPPLY DELAY. Shortage can be intermittent as Sanofi may receive partial shipments, until full resolution expected on “Estimated end date”. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-01-02 | French | Compare |
| v6 | 2024-01-02 | English | Compare |
| v5 | 2023-12-05 | French | Compare |
| v4 | 2023-12-05 | English | Compare |
| v3 | 2023-11-14 | English | Compare |
| v2 | 2023-11-07 | French | Compare |
| v1 | 2023-11-07 | English | Compare |
Showing 1 to 7 of 7